STOCK TITAN
  1. Home
  2. Sec-filings
  3. CELC
  4. [Form 4] Celcuity Inc. Insider Trading Activity

Celcuity Inc. (CELC) director exercises 7,917 warrants for common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Celcuity Inc. director Richard Nigon reported exercising warrants to acquire a total of 7,917 shares of Celcuity common stock in two tranches of 4,672 and 3,245 shares at an exercise price of $7.5628 per share on September 11, 2025. After these transactions he directly holds 109,010 common shares.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Director purchases totaling 7,917 shares at $7.5628 increase direct ownership to 109,010 shares; warrants also recorded and currently exercisable.

The filing shows a director-level insider acquiring common stock in two transactions on 09/11/2025 for a combined 7,917 shares at $7.5628 per share, moving reported direct ownership from 101,838 shares (implied) to 109,010 shares according to the sequential ownership figures disclosed. The inclusion of warrants tied to the same share counts and with exercisability noted indicates the reporting captures both immediate equity and associated derivative instruments. For investors, insider purchases by directors are a signal of alignment with shareholder interests, while the warrants introduce potential future dilution if exercised. All conclusions are strictly limited to facts disclosed in the Form 4.

TL;DR: Disclosure is straightforward: director-level acquisitions and associated warrants were timely reported and signed by an attorney-in-fact.

The Form 4 documentation is complete for the transactions disclosed: it identifies the reporting person as a director, lists transaction dates, share amounts, prices, and the exercise/expiration information for warrants. The signature block shows the filing was executed by an attorney-in-fact on 09/15/2025. There are no allegations, amendments, or corrective statements in the provided content. This is a routine insider transaction disclosure consistent with Section 16 reporting requirements.

Insider NIGON RICHARD
Role Director
Type Security Shares Price Value
In-the-Money Exercise Warrants (right to buy) 4,672 $0.00 $0.00
In-the-Money Exercise Warrants (right to buy) 3,245 $0.00 $0.00
In-the-Money Exercise Common Stock 4,672 $7.5628 $35K
In-the-Money Exercise Common Stock 3,245 $7.5628 $25K
Holdings After Transaction: Warrants (right to buy) — 0 shares (Direct); Common Stock — 109,010 shares (Direct)
Footnotes (1)
  1. F1. Currently exercisable.
Warrants Exercised 7,917 shares Total shares underlying warrants exercised on September 11, 2025
First Warrant Tranche 4,672 shares Shares underlying a warrant expiring January 14, 2026
Second Warrant Tranche 3,245 shares Shares underlying a warrant expiring May 2, 2026
Exercise Price $7.5628 per share Conversion or exercise price for Celcuity common stock acquired via warrants
Post-transaction Holdings 109,010 shares Direct Celcuity common stock owned by Richard Nigon after the reported exercises
Warrants (right to buy) financial
"Derivative security_title listed as Warrants (right to buy)."
in-the-money derivative exercise financial
"transaction_action described as in-the-money derivative exercise."
conversion or exercise price financial
"Field conversion_or_exercise_price shows 7.5628 as the price."

FAQ

What insider transaction did Celcuity (CELC) director Richard Nigon report?
Richard Nigon reported exercising warrants to acquire 7,917 shares of Celcuity common stock on September 11, 2025, in two tranches at an exercise price of $7.5628 per share, resulting in direct ownership of 109,010 shares after the transactions.

How many Celcuity (CELC) warrants did Richard Nigon exercise and at what price?
He exercised warrants covering 7,917 shares of Celcuity common stock, consisting of 4,672 and 3,245-share tranches. The reported conversion or exercise price for these in-the-money derivative exercises was $7.5628 per share for the underlying common stock.

What is Richard Nigon’s Celcuity (CELC) common stock holding after this Form 4?
Following the reported warrant exercises, Richard Nigon directly holds 109,010 shares of Celcuity common stock. This post-transaction balance reflects his direct ownership position as recorded in the insider filing’s canonical holdings section.

Did the Celcuity (CELC) Form 4 show any open-market stock sales by Richard Nigon?
The Form 4 reports warrant exercises and corresponding common stock entries coded as derivative exercises, but no transactions coded as open-market purchases or sales. The transaction summary shows zero buy and sell shares, with activity limited to derivative exercises.

What types of securities are involved in Richard Nigon’s Celcuity (CELC) transactions?
The transactions involve warrants (right to buy) as derivative securities and the resulting Celcuity common stock. Two warrant positions were exercised, each converting into common shares, and the filing notes these as in-the-money derivative exercises.

Were Richard Nigon’s Celcuity (CELC) warrants currently exercisable at the time of reporting?
A footnote states that the warrants were “Currently exercisable”, providing context that the derivative securities could be exercised at the time. The reported Form 4 then shows these warrants being exercised into Celcuity common stock on September 11, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
NIGON RICHARD
(Last) (First) (Middle)
16305 36TH AVE N
SUITE 100
(Street)
MINNEAPOLIS MN 55446
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Celcuity Inc. [ CELC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/11/2025 X 4,672 A $7.5628 105,765 D
Common Stock 09/11/2025 X 3,245 A $7.5628 109,010 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants (right to buy) $7.5628 09/11/2025 X 4,672 (1) 01/14/2026 Common Stock 4,672 $0 0 D
Warrants (right to buy) $7.5628 09/11/2025 X 3,245 (1) 05/02/2026 Common Stock 3,245 $0 0 D
Explanation of Responses:
1. Currently exercisable.
/s/ Griffin D. Foster, Attorney-in-Fact for Richard J. Nigon 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR